HUMAN CYTOSOLIC SULFOTRANSFERASES
人细胞溶质磺基转移酶
基本信息
- 批准号:6196211
- 负责人:
- 金额:$ 25.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-07-01 至 2004-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The overall goal of this project is to investigate the biochemistry and molecular biology of the human cytosolic sulfotransferases (STs) and to understand the role of sulfation in the metabolism of drugs, xenobiotics and endogenous substrates in normal and cancerous human tissues. Sulfation is involved in the metabolism and regulation of activity of many endogenous compounds including steroid and thyroid hormones, monoamine neurotransmitters, vitamins, and bile acids. The sulfation of steroid hormones is important in the regulation of hormonal activity in human tissues. Steroid sulfates are inactive because steroid sulfates do not bind to their receptors and initiate a cellular response. At least six human STs can sulfate estrogenic compounds; however, because of its high affinity for beta- estradiol (E2), estrogen ST (EST, SULT1E1) is the ST involved in inactivating estrogens in estrogen responsive tissues such as endometrium and breast. During the previous funding periods of this grant, the number of identified human cytosolic STs has increased to ten. Little is known as to the protein chemistry or molecular biology of these newly identified forms of ST. Even less is known about the physiological functions of the ST isoforms. We believe that this fundamental biochemical information will improve our understanding of human drug metabolism and provide information for drug design and therapy as well as increase our knowledge of the functions of sulfation in cellular physiology. We have also identified a novel form of human ST-like protein, BR-STL, selectively expressed in human brain tissues. Thus, this proposal focuses on the investigation of the role of the STs in regulating estrogen responsiveness of normal and cancerous breast cells, as well as on the characterization of three novel human cytosolic STs which have been recently identified. The Specific Aims of this proposal are: 1) to analyze the expression and role of EST and the PSTs in regulating estrogenic activity in human normal and cancerous breast tissue and 2) to characterize the properties and functions of the recently described human STs, ST2B1a, ST2B1b and ST1C1, and the ST-like protein BR-STL.
该项目的总体目标是研究人类胞质硫转移酶(STs)的生物化学和分子生物学,并了解硫酸化在正常和癌变人体组织中药物、异种生物和内源性底物代谢中的作用。硫酸化参与许多内源性化合物的代谢和活性调节,包括类固醇和甲状腺激素、单胺类神经递质、维生素和胆汁酸。类固醇激素的磺化在调节人体组织中的激素活性方面是重要的。类固醇硫酸盐是无活性的,因为类固醇硫酸盐不能与受体结合并引发细胞反应。至少六种人体STs可以硫酸盐雌激素化合物;然而,由于其对β -雌二醇(E2)的高亲和力,雌激素ST (EST, SULT1E1)是雌激素应答组织(如子宫内膜和乳房)中参与雌激素失活的ST。在此拨款的前几个资助期内,已确定的人类细胞质性STs数目已增至10个。对这些新发现的ST亚型的蛋白质化学或分子生物学知之甚少,甚至对ST亚型的生理功能也知之甚少。我们相信这些基本的生物化学信息将提高我们对人类药物代谢的理解,为药物设计和治疗提供信息,并增加我们对硫酸盐在细胞生理学中的功能的认识。我们还发现了一种新的人st样蛋白BR-STL,它在人脑组织中选择性表达。因此,本研究的重点是研究STs在调节正常和癌乳腺细胞雌激素反应中的作用,以及最近发现的三种新的人类细胞质STs的特性。本课题的具体目的是:1)分析EST和PSTs在人正常和癌性乳腺组织中的表达及其在调节雌激素活性中的作用;2)表征最近发现的人st、ST2B1a、ST2B1b和ST1C1以及st样蛋白BR-STL的特性和功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles N Falany其他文献
Charles N Falany的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles N Falany', 18)}}的其他基金
STRUCTURE AND REGULATION OF RAT ARYL SULFOTRANSFERASES
大鼠芳基磺基转移酶的结构和调控
- 批准号:
3297968 - 财政年份:1991
- 资助金额:
$ 25.11万 - 项目类别:
STRUCTURE AND REGULATION OF RAT ARYL SULFOTRANSFERASES
大鼠芳基磺基转移酶的结构和调控
- 批准号:
3297967 - 财政年份:1989
- 资助金额:
$ 25.11万 - 项目类别:
STRUCTURE AND REGULATION OF RAT ARYL SULFOTRANSFERASES
大鼠芳基磺基转移酶的结构和调控
- 批准号:
3297966 - 财政年份:1989
- 资助金额:
$ 25.11万 - 项目类别:
STRUCTURE AND REGULATION OF RAT ARYL SULFOTRANSFERASES
大鼠芳基磺基转移酶的结构和调控
- 批准号:
3297965 - 财政年份:1989
- 资助金额:
$ 25.11万 - 项目类别:
相似海外基金
Elucidation of endoplasmic reticulum transporters in drug metabolism
阐明药物代谢中的内质网转运蛋白
- 批准号:
23H02648 - 财政年份:2023
- 资助金额:
$ 25.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
2023 Drug Metabolism Gordon Research Conference and Gordon Research Seminar
2023年药物代谢戈登研究会议暨戈登研究研讨会
- 批准号:
10751553 - 财政年份:2023
- 资助金额:
$ 25.11万 - 项目类别:
In vitro assessment of kratom pharmacokinetic CYP interactions with HIV ART drug metabolism
卡痛叶药代动力学 CYP 与 HIV ART 药物代谢相互作用的体外评估
- 批准号:
10746628 - 财政年份:2023
- 资助金额:
$ 25.11万 - 项目类别:
Hormone mediated mechanisms of altered drug metabolism and transport in transgender adults
跨性别成人药物代谢和转运改变的激素介导机制
- 批准号:
10506038 - 财政年份:2022
- 资助金额:
$ 25.11万 - 项目类别:
Mechanism Of Enterococcus Faecalis Nitro Drug Metabolism And In Vivo Implications
粪肠球菌硝基药物代谢机制及其体内影响
- 批准号:
10511022 - 财政年份:2022
- 资助金额:
$ 25.11万 - 项目类别:
Development of a drug metabolism capacity and interaction evaluation system for the elderly with sarcopenia and avoidance of adverse drug reaction risks.
建立老年人肌少症药物代谢能力及相互作用评价体系,避免药物不良反应风险。
- 批准号:
22K06763 - 财政年份:2022
- 资助金额:
$ 25.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Comprehensive pathway generation of drug action and drug metabolism for DrugBank
DrugBank 药物作用和药物代谢的综合路径生成
- 批准号:
565707-2021 - 财政年份:2022
- 资助金额:
$ 25.11万 - 项目类别:
Alliance Grants
Computational prediction of gut microbiome-mediated drug metabolism
肠道微生物介导的药物代谢的计算预测
- 批准号:
10558540 - 财政年份:2022
- 资助金额:
$ 25.11万 - 项目类别:
Inter-Enzyme Crosstalk in the Cytochrome P450 Ensemble: Implications for the Effects of Alcohol on Drug Metabolism and Alcohol-Drug Interactions
细胞色素 P450 整体中的酶间串扰:酒精对药物代谢和酒精-药物相互作用影响的影响
- 批准号:
10704053 - 财政年份:2022
- 资助金额:
$ 25.11万 - 项目类别:
SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK].
药物代谢药代动力学 [DMPK] 主题专家顾问。
- 批准号:
10721124 - 财政年份:2022
- 资助金额:
$ 25.11万 - 项目类别: